News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Alex Keown

news@biospace.com

BioSpace News - By Alex Keown
Embattled Theranos Plans to Appeal to Re-Open Its Lab in Newark, California 8/26/2016
Job Cuts Loom as Takeda (TKPYY) to Shutter Cambridge Office and Quits the UK 8/25/2016
Facing Public Backlash and Pressure from Clinton, Mylan (MYL) Caves and Lowers Price of EpiPen 8/25/2016
Best Places to Work in Life Sciences for LGBT Equality 8/25/2016
Teva (TEVA) Stock Plummets After Two Patents are Invalidated by Mylan (MYL) 8/25/2016
Mylan (MYL) CEO Gets a 600% Pay Raise During Epipen's 400% Price Hike, Is She the Next Martin Shkreli? 8/25/2016
McKesson (MCK) Slaps 'For Sale' Sign on San Francisco HQ With Plans to Lease Back a Portion of Building 8/25/2016
Months After Infamous 'Sexist' Biotech Party, 20 Women Join New Exec Training 8/25/2016
Turing CCO Claims Execs Retaliated After Shkreli’s Friend and Co-Founder Resigned Due to Sexual Assault Allegations 8/25/2016
MIT Scientist Leonard Guarente Claims That This Pill Is the Fountain of Youth 8/25/2016
Valeant (VRX) Offers Details on Incoming CFO's Compensation; Will Get $10 Million in 'Make-Up Cash' 8/24/2016
Outrage Ensues After Mylan (MYL) Raises EpiPen Price by 400% 8/24/2016
Pfizer (PFE) to Shut Down Four Hospira Distribution Centers 8/24/2016
Merrion Pharma Looks to Wind Up Operations, Announces Liquidation Plans 8/23/2016
Advaxis (ADXS)' Resurrection and the Man Behind It All 8/23/2016
Google (GOOG)'s Verily HQ in the Peninsula Needs More Time, Company Seeks Timeline Extension 8/23/2016
Rumors Again Swirl Over BioMarin (BMRN) Being a Possible Plan B for Sanofi (SNY) 8/23/2016
DS Biopharma Spins Out New Company Focused on Fibrotic Conditions and Pulmonary Disorders 8/22/2016
Booming Arbutus Biopharma (ABUS) Relocating HQ to Warminster for More Space 8/22/2016
Nephron Pharma Chops Another 60 Jobs as it Transitions Out of Florida and Into New South Carolina HQ 8/22/2016
Korean Firms Acquire Novo Nordisk A/S (NVO)’s U.S. HQ for $305 Million 8/19/2016
2 Under-the-Radar Cancer Stocks That are in the Bargain Bin Right Now 8/19/2016
Trial Failure Prompts Cerulean (CERU) to Pink Slip 48% of Workforce 8/19/2016
Mallinckrodt (MNK) to Build New $80 Million+ Campus in New Jersey With Space for 400 Employees 8/19/2016
Juno (JUNO) Facing Class Action Lawsuit Following Patient Deaths 8/19/2016
19 Deaths Force Medtronic (MDT) to Warn Doctors on Heart Valve Delivery System 8/18/2016
Martin Shkreli's Former Firm Retrophin (RTRX) Considering Acquisition of Bay Area's Raptor (RPTP), Deal Could be Worth $589 Million+ 8/18/2016
Merck & Co. (MRK) Slashes 148 Jobs, Shuts Down Screening Plant in Montgomery County, Pennsylvania 8/18/2016
Life Sciences Symposium Lands Pharma Bro Martin Shkreli for Program Lineup 8/17/2016
GlaxoSmithKline (GSK) Best-Selling Weight Loss Pill Cramped By Problematic Studies That Understated Its Harms 8/17/2016
SEC Filing Reveals NW Bio (NWBO) May No Longer be Capable of Paying Its Operating Expenses 8/17/2016
Vertex (VRTX) Dumps Phase III Cystic Fibrosis Study 8/17/2016
Recordati CEO Dies; Drug Giant Urgently Names New CEO 8/17/2016
Roche (RHHBY), Eleven Bio (EBIO) Ink $270 Million Exclusive Licensing Deal 8/17/2016
Chiasma Enforces Job-Cutting Scheme, Axing a Further 44% of Workforce 8/16/2016
Bristol-Myers Squibb (BMY) Investors: Wait on Opdivo Data to See Potential in Lung Cancer 8/15/2016
Bayer HealthCare (BAY) to Lay Off Researchers in San Francisco's Mission Bay 8/15/2016
Amid Multi-Million Financing and Expanding Exec Management, SoCal's NovaRx Changes Company Name 8/15/2016
ProNAi Therapeutics Shuts Down Research Site for Failed Cancer Candidate PNT2258 8/15/2016
Struggling Eleven Bio (EBIO) Explores Sale of the Company 8/12/2016
Six Former and Current Novartis AG (NVS) Execs Charged With Bribing Doctors in Korea 8/12/2016
Investment Consultant and Lawyer Accused of Insider Trading Ahead of Pfizer (PFE)'s 2010 Acquisition of King Pharma 8/12/2016
Genome Revolution Drives Bay Area Teknova to Grow by 40 Percent; Company Wants to Expand and Double Workforce 8/12/2016
Novartis AG (NVS) Faces Potential Sales Ban in South Korea Amid Corruption Allegations 8/12/2016
Abbott (ABT) Managers in India Allegedly Instructed Employees to Pursue Sales at Any Cost 8/11/2016
Ranbaxy Laboratories (RANBAXY.BO) Owners ‘Deliberately Buried’ Information From Daiichi Sankyo: Singapore Tribunal Order 8/11/2016
Full Spectrum Analytics Provides the Total Fix for the Customer 8/11/2016
Eli Lilly (LLY)'s Breast Cancer Drug Failed to Meet Phase III Goals, But Panel Recommends Continuation of Trial 8/10/2016
Agilent (A) Snaps Up 20 Acres in Colorado to Build Facility, Will Create Up to 200 New Jobs 8/10/2016
Biogen (BIIB) Unveils Name for New Standalone Hemophilia-Focused Company: Bioverativ 8/10/2016
AstraZeneca PLC (AZN)'s Lung Cancer Drug Flunks Late-Stage Test 8/10/2016
Baxter International (BAX), Torrent Pharma and Others Reportedly in Talks to Acquire CLARIS U.S. Injectables Unit 8/10/2016
Embattled Valeant (VRX) to Finally Reorganize, CEO Urges Patience 8/9/2016
Bristol-Myers Squibb (BMY)'s $4 Billion Disaster Sends Partner Ono Pharma (OPHLY)'s Stock Plunging 8/9/2016
WuXi AppTec's Subsidiary to Open Up Shop in San Diego 8/9/2016
Cytel President Explains Benefits of Adaptive Trial Design 8/9/2016
Bay Area's Cleave Biosciences Rakes in $37 Million With Help From New Investor Celgene (CELG) 8/8/2016
Doctor Charged With Insider Trading While Heading a Clinical Trial for Regado Biosciences (RGDO) 8/8/2016
Some AACC Scientists Quit the Organization Over Theranos CEO’s High-Profile Speaking Slot 8/8/2016
Vaxart Challenges Takeda (TKPYY) with Oral Norovirus Vaccine 8/8/2016
Bristol-Myers Squibb (BMY)'s Failed Lung Cancer Data Sends Stock Plunging 8/5/2016
Ionis Pharma (IONS) Investors Still Nervous Despite Upbeat Trial Data Presented Earlier This Week 8/5/2016
AstraZeneca PLC (AZN) Firing and Hiring at Its Mt. Vernon Facility 8/5/2016
FDA Warns Chinese Drugmaker Xiamen Origin Biotech Over Making False Statements to Regulators 8/5/2016
Year-Old Startup Decibel Therapeutics Inks Lease for Huge New HQ in Boston 8/5/2016
McKesson (MCK) to Increase Headcount at Iowa Facility 8/5/2016
Chemours HQ to Stay Put, Keeping 1,000 Jobs in Delaware 8/4/2016
Chemours to Begin First Wave of Niagara Falls Layoffs on Halloween, Second Wave on Dec. 31 8/4/2016
Theranos CEO Quietly Steps Down as Obama's Presidential Ambassador for Entrepreneurship 8/4/2016
Mayne Pharma Commits $80 Million to North Carolina Expansion After Acquiring 42 Products from Allergan (AGN), Teva (TEVA) 8/4/2016
Amgen (AMGN) Forges Pre-clinical R&D Pact Worth $540 Million With Advaxis (ADXS) 8/4/2016
7 Biotech Stocks Investors Should Keep Their Eye On in 2017 8/3/2016
Another Round of Layoffs for Pfizer (PFE) in New York 8/3/2016
GlaxoSmithKline (GSK), Google (GOOG)'s Verily Create $715 Million Bioelectronic Medicines Firm 8/3/2016
India's Aurobindo Pharma (AUROBINDOP.BO) Breaks Ground on U.S. HQ, Will Create Up to 400 Jobs 8/3/2016
Celgene (CELG) Accused of Donating Millions to Charities as Part of a Business 'Scheme to Gain Billions’ 8/3/2016
Struggling Telesta (TSX:TST) Cuts Another 30% of Workforce, Will Shutter Montreal Facility 8/2/2016
Embattled Theranos and Elizabeth Holmes' Next Bet: Project Edison 8/2/2016
Tokai Pharma (TKAI) Axes 60% of Workforce After Phase III Prostate Cancer Trial Failure 8/1/2016
Once-Booming NewLink Genetics (NLNK) to Eliminate 100 Jobs in Reorg 8/1/2016
In Revamp, Takeda (TKPYY) to Now Focus on Three Therapeutic Areas and Concentrate R&D Activities in Japan and the U.S. 8/1/2016
Theranos Will Finally Step Up to the Scientific Spotlight Next Week But Doubts Abound 7/29/2016
Seres Therapeutics (MCRB) Craters in Phase II ECOSPOR Study; CEO and Execs Profit on Insider Sales 7/29/2016
Amgen (AMGN) Restructuring Plan That Laid Off Hundreds Is Paying Off, CEO Says 7/29/2016
Pfizer (PFE) Plans $146 Million Expansion in Michigan 7/29/2016
Unilife  (UNIS) Axes 40% of Workforce, Names New CEO 7/28/2016
Eli Lilly (LLY)'s Longtime CEO to Retire, Successor Named 7/28/2016
Future Eli Lilly (LLY) CEO Says Dealmaking Will Be a Focus 7/28/2016
With Hopes of Bolstering Sanofi (SNY)’s Sagging Diabetes Sector, Announces FDA Approval of Adlyxin in U.S. 7/28/2016
Why Gilead (GILD) Should Take a Page Out of Celgene (CELG)'s Playbook, But Will Have Trouble Doing So 7/28/2016
Miniature Microscopy Company Mauna Kea Technologies Takes New Approach to Commercial Strategy 7/28/2016
Boehringer Ingelheim Halts Two Phase III Trials for Lung Cancer Drug Gilotrif 7/27/2016
Abbott (ABT) Sales Rep in India Blames Company in Suicide Note 7/27/2016
400+ Women are Suing Drug Giant Merck & Co. (MRK) Over Unequal Pay 7/27/2016
Clinton Running Mate Tim Kaine Scrutinized for Private Plane Ride Provided by Teva (TEVA) Subsidiary 7/26/2016
French-Based Firm Advanced Accelerator Applications Opens Up Shop in New Jersey, Plans to Hire 7/26/2016
Following Revelations of ‘Flawed Studies’ in Clinical Trials, EMA Recommends Suspending Drugs; Many of Which Belong to Novartis AG (NVS) and Teva (TEVA) 7/26/2016
Takeda (TKPYY) May Sell Some Non-Core Assets to Raise Cash 7/26/2016
Tobira (TBRA) Stock Loses More Than Half Its Value After Phase IIb Trial Miss 7/25/2016
Galenica (GALN.SW) to Acquire Bay Area's Relypsa (RLYP) for $1.53 Billion 7/22/2016
3 Biotech Stocks That Could Explode in the Next 12 Months 7/22/2016
FDA Rejects Valeant (VRX) Glaucoma Drug, Raises Concerns Over Manufacturing Issues 7/22/2016
Fresenius SE Bid for Pfizer (PFE)'s Pump Biz Stalled, Pfizer Seeking Other Attractive Offers 7/22/2016
In Effort to Reform, Struggling Theranos Hires New Chiefs to Help Pull It Out of Its Ditch 7/22/2016
Drug Giant Merck & Co. (MRK) to Set Up Shop in South San Francisco 7/21/2016
Struggling Aegerion (AEGR) Axes 13% of Workforce, Withdraws Cholesterol Drug from the EU 7/21/2016
Celgene (CELG) Exec Takes Leave to Work on Trump Campaign 7/21/2016
GHO Capital Announces Acquisition Of Caprion (CAPR) 7/20/2016
Startup Bioz Launches With First Search Engine Built for Life Science Research 7/20/2016
Amgen (AMGN) and Merck KGaA (MKGAF.PK) Invest in Boston's Akili, Increasing Funding Round to $42.4 Million 7/20/2016
Merck KGaA (MKGAF.PK) Starts Construction on $115 Million Life Sci Hub in Massachusetts 7/19/2016
SoCal's Ionis Pharma (IONS) Cuts GI Deal Worth $810 Million With Janssen Biotech (JNJ) 7/19/2016
Former Epizyme (EPZM) CEO Helms Fulcrum Therapeutics; New Startup Banks $55 Million Series A 7/19/2016
Genentech (RHHBY) Receives a Blow After Lymphoma Drug Flunks Phase III Test 7/19/2016
Why Drugmakers like Merck & Co. (MRK), Shire (SHPG) and AstraZeneca PLC (AZN) Leave Philadelphia for Boston 7/19/2016
R&D Logic Provides Fourth Dimension Solution to Life Science Finance Software Platform 7/19/2016
FDA Panel Divided on Valeant (VRX)'s Psoriasis Drug Suicide Risk 7/18/2016
3 Big Pharmas That Have Plenty of Cash to Pay Out Investors 7/18/2016
Employee Taken to Hospital After Genentech (RHHBY) Hazmat Spill in South San Francisco 7/18/2016
Pharma Bro Martin Shkreli Gets Trial Date, Couldn’t Wait to Play Pokémon Go After Hearing 7/18/2016
European Regulator Calls XBiotech (XBIT)'s Phase III Cancer Data Unreliable 7/15/2016
Merck & Co. (MRK) Plans to Open Microbiome R&D Site in Former Idenix (IDIX) Facility in Cambridge 7/15/2016
NanoString (NSTG) Expands; New Biotech Silverback Therapeutics Sets Up Shop 7/14/2016
Germany's Vetter Plans to Hire 300 to Staff New Facility in Illinois 7/14/2016
Gilead (GILD) Used Legal Loopholes to Avoid Paying $10 Billion in Taxes Last Year 7/14/2016
Theranos Says Elizabeth Holmes Will Remain CEO, But it May Stop All Lab Operations 7/13/2016
Amgen (AMGN) Inches Closer to Selling Cheaper Version of AbbVie (ABBV)'s Blockbuster Humira 7/13/2016
Boston Filmmaker Plans to Make a Movie About the Early Days of Vertex (VRTX) 7/13/2016
Good News for Gilead (GILD) as Zydelig Passes Safety Review Test Despite Trial Deaths 7/12/2016
Evelo and Epiva Merge to Become a Leading Immuno-Microbiome Platform Company 7/12/2016
3 Nauseating Clinical Trial Flops of 2016 So Far 7/12/2016
4 High-Quality Biotechs Trading Like Risky Startups 7/12/2016
This Neglected Big Pharma Stock Could be About to Explode 7/11/2016
Theranos CEO Elizabeth Holmes Banned from Operating a Lab for Two Years 7/11/2016
Congress Demands Theranos CEO Explain What Went Wrong 7/8/2016
AbbVie (ABBV)'s $175 Million Gamble Pays Off as Ablynx (ABLYF) RA Drug Meets Goal in Phase II Study 7/8/2016
BioMarin (BMRN) Shoots Up on Roche (RHHBY) Takeover Rumor 7/8/2016
2 Fallen Biotech Stocks Worth Chasing 7/8/2016
Investors Look to the Future of AbbVie (ABBV) Post-Patent Protection for Humira 7/8/2016
KaloBios (KBIO) Enters Deal to Buy Back Former CEO Martin Shkreli's Shares 7/8/2016
Pfizer (PFE)'s Growth Strategy: Turning to Smaller M&As 7/7/2016
Roche (RHHBY) to Slash Approximately 350 IT Jobs by End of 2017 7/7/2016
10 Biotech Stocks that Could Blow Up in Q3 7/6/2016
BIND Therapeutics (BIND) Stock Soars After Accepting Pfizer (PFE)’s ‘Stalking Horse’ Asset Bid 7/6/2016
XBiotech (XBIT)'s Colorectal Cancer Drug Claims Fall Apart, Shares Plummet 7/6/2016
285 Jobs at Risk as Biogen (BIIB) to Stop Producing Drugs at Its Cambridge Plant 6/30/2016
100+ Jobs Gone as Pfizer (PFE) to Shut Down Boulder Facility 6/28/2016
AstraZeneca PLC (AZN), GlaxoSmithKline (GSK), Novartis AG (NVS) and Roche (RHHBY) React to Brexit and Its Possible Impact on Biotech 6/27/2016
British Trade Group Suspends Astellas (ALPMY) After Drugmaker Disguised the True Purpose of a Meeting Held for Doctors 6/27/2016
Takeda (TKPYY) Returns Certain Molecules, Products to Amgen (AMGN) 6/27/2016
Sanofi (SNY) Gears Up for Second Round of Innovation Awards Grants 6/27/2016
What Happens to Merck KGaA (MKGAF.PK) Jobs After the UK Voted Brexit 6/24/2016
Cambridge's Eleven Bio (EBIO) Pink Slips 70% of Workforce in Restructuring 6/24/2016
A Look into NW Bio (NWBO)'s Downfall: Bad Management or Short Sellers? 6/24/2016
Two Bay Area Startups Win Amgen (AMGN)'s Golden Ticket Award 6/24/2016
GE Healthcare Opens Up $27 Million, 500-Job Facility in Massachusetts 6/24/2016
Hedge Fund Exec Accused of Paying Former FDA Official for Inside Information Found Dead in Apparent Suicide 6/24/2016
Massachusetts-Based Radius Health (RDUS) Opens Up Shop in Philadelphia with Plans to Hire 100+ Employees 6/23/2016
31-Year-Old Rachel Haurwitz Helms Hot CRISPR-Based Biotech Firm Caribou Biosciences 6/23/2016
AstraZeneca PLC (AZN) Takes a $80 Million Hit as the CDC Says Flu Vaccine Flumist Does Not Work 6/23/2016
What Pfizer (PFE) Could Look Like If it Breaks Up 6/23/2016
Sanofi (SNY) Partners Successfully with UMass Boston in Undergraduate STEM Program 6/23/2016
Kite Pharma (KITE) Opens Up New T-Cell Therapy Manufacturing Plant in California 6/22/2016
Donors from Top 15 Drug Firms Drop Cash onto Presidential Candidate Hillary Clinton 6/22/2016
3 Big Data Risks Pharma Should Fear 6/22/2016
Silicon Valley Tech Titan Sean Parker to Back First CRISPR Test 6/22/2016
Opko Health (OPK) Rockets on FDA Approval of Rayaldee Four Months Ahead of PDUFA Date 6/22/2016
Immunomedics (IMMU) CFO Steps Down, Stock Has Fallen Steadily Since ASCO Fiasco 6/22/2016
Biogen (BIIB)'s Cambridge Manufacturing Move Means More Work for the 1,300 Workers in North Carolina 6/21/2016
3 Big Pharmas Investors Should Take a Look At 6/20/2016
Endocyte (ECYT) Co-Founder Resigns Effective Immediately as CEO, New Leader Named 6/20/2016
Theranos is Finally Going to Share Data on Its Blood Tests in August 6/17/2016
Scancell (SCNLF) Suspends Dosing in Melanoma Trial Due to Quality Issues 6/17/2016
Former FDA Official Charged in Alleged Securities Scheme for Tipping Off Hedge Fund 6/16/2016
As Theranos Gets Dumped by Walgreens, Rival Quest Diagnostics (DGX) Moves into More Safeway Locations 6/16/2016
Google (GOOG)'s Verily Taps Communications Chief to Craft Company Message and Battle Media Criticism 6/16/2016
Shire (SHPG) Nabs Breakthrough Tags for Drug to Treat Rare Gastrointestinal Conditions 6/15/2016
Arena (ARNA) Board Terminates CMO Without Cause, Effective Immediately 6/15/2016
New York Startup Rgenix Bags $33 Million, Gears Up to Push Drug Once-Shelved by GlaxoSmithKline (GSK) into Trial 6/15/2016
Struggling Chiasma Chops 33% of Workforce After FDA Drug Rejection 6/15/2016
Beleaguered Cambridge Drugmaker Aegerion (AEGR) Merges with QLT (QLTI) to Survive 6/15/2016
Pfizer (PFE)-Backed Ziarco Exploring Sale, Deal Could Bring in $1 Billion+ 6/15/2016
Infinity Pharma (INFI) to Eliminate 46 Researchers After Lymphoma Drug Disappoints in Study 6/14/2016
Intarcia to Move HQ Next Month, Plans to Double Workforce By End of 2017 6/14/2016
Mesoblast (MSB.AX) Stock Sinks 42% After Teva (TEVA) Withdraws from Heart Failure Trials 6/14/2016
Novo Nordisk A/S (NVO) Investors Disappointed as Top Selling Drug Victoza Didn't Do as Well as Expected 6/14/2016
Jennifer Lawrence Signs On to Play Elizabeth Holmes in Movie About Embattled Theranos 6/13/2016
Struggling Eleven Bio (EBIO) Forges Deal Worth $270 Million with Pharma Giant Roche (RHHBY) 6/13/2016
Walgreens Breaks Ties With Theranos, Will Shutter All 40 Wellness Centers 6/13/2016
Pfizer (PFE) Quietly Raised Drug Prices By an Average of 8.8% Last Week 6/10/2016
Biogen (BIIB)'s $8 Billion Market Cap Drop Makes Thermo Fisher Scientific (TMO) the New King in Massachusetts, But GE Corporation (GE)’s Coming to Town 6/10/2016
BIO2016: French Firm Biose to Open U.S. HQ in Cambridge to Look for Partners 6/10/2016
Top Alphabet Exec Defends Google (GOOG)'s Verily Amid Criticism 6/9/2016
Boston Scientific (BSX) Aims for Major Cost Reductions in Global Restructuring 6/9/2016
Valeant (VRX) Scrambles to Restructure Deal with Walgreens 6/9/2016
BIO2016: Ireland Still Attracting Biotech, Pharma Companies to Set up Shop 6/9/2016
BIO2016: Months After Infamous "Sexist" Biotech Party, LifeSci Advisors Finds New Ways to Showcase Women 6/9/2016
Could Google (GOOG)'s Verily be the Next Theranos? 6/9/2016
Federal Judge Reverses Merck & Co. (MRK)’s $200 Million Patent Win Against Gilead (GILD) Over False Testimony 6/9/2016
BIO2016: Pharma Business Models Are Predicted To Shift To Patient Outcomes And Value 6/8/2016



//-->